• About us
• Contact

Advertisement

Organisation › Details

Prophyta Biologischer Pflanzenschutz GmbH

Prophyta, founded in 1992, provides customers well-established products primarily based on biological control agents. For example, its nematicide BioAct™ is available in 10 countries. Prophyta has developed a unique solid-state fermentation technology for production and bioprocess development of filamentous fungi. The company employs a total staff of approximately 30 full-time employees. *

 

	Start	1992-01-01 established
	Group	Bayer (Group)
	Industry	plant biotechnology
	Industry 2	AGRI LIFE SCIENCES
	Person	Lüth, Peter (Prophyta GmbH 201301 Managing Director + Co-founder)
	Region	Malchow
	Country	Germany
	Street	12 Inselstr.
	City	23999 Malchow/Poel
	Tel	+49-38425-23-0
		Address record changed: 2020-12-02
Basic data	Employees	B: 11 to 50 (2013-01-21)
		* Document for »About Section«:
		Record changed: 2025-03-16

Advertisement

More documents for Bayer (Group)

• [1] Bayer AG. (3/26/25). "Press Release: Bayer and Puhe BioPharma Enter into Global License Agreement for Clinical Phase I PRMT5 inhibitor [Not intended for U.S. and UK Media]". Berlin & Beijing....
• [2] Roivant Sciences GmbH. (9/10/24). "Press Release: Roivant Unveils New Pipeline Program Mosliciguat, a Potential First-In-Class and Best-In-Category Inhaled Once-Daily Soluble Guanylate Cyclase (sGC) Activator". Basel, London & New York, NY....
• [3] NextRNA Therapeutics, Inc.. (8/28/24). "Press Release: Bayer and NextRNA Therapeutics Enter Strategic Collaboration to Develop Small Molecules Targeting Long Non-coding RNAs (lncRNAs) in Oncology". Berlin & Boston, MA....
• [4] Bayer AG. (7/17/24). "Press Release: Darolutamide Meets Primary Endpoint in Phase III ARANOTE Trial in Men with Metastatic Hormone-sensitive Prostate Cancer [Not intended for U.S. and UK Media]". Berlin....
• [5] BlueRock Therapeutics LP. (5/30/23). "Press Release: BlueRock Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for Parkinson’s Disease Cell Therapy Candidate Bemdaneprocel". Berlin & Cambridge, MA....
• [6] H. Lundbeck A/S. (5/13/24). "Press Release: Maria Alfaiate Appointed New Executive Vice President Commercial and Corporate Strategy at Lundbeck"....
• [7] WhiteLab Genomics. (5/6/24). "Press Release: WhiteLab Genomics Establishes US Presence by Securing Spot at Bayer Co.Lab and Ginkgo Bioworks’ Technology Network". Cambridge, MA....
• [8] Evotec SE. (4/30/24). "Press Release: Bayer and Evotec Collaborate to Advance Precision Cardiology". Berlin & Hamburg....
• [9] ProBioGen AG. (4/30/24). "Press Release: Change in Management". Berlin....
• [10] Aignostics GmbH. (3/14/24). "Press Release: Bayer and Aignostics to Collaborate on Next Generation Precision Oncology"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.